News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
185 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (31)
2 (29)
3 (279)
4 (239)
5 (185)
6 (219)
7 (134)
8 (5)
9 (2)
10 (218)
11 (255)
12 (223)
13 (194)
14 (151)
15 (4)
16 (14)
17 (221)
18 (253)
19 (211)
20 (239)
21 (133)
22 (2)
23 (4)
24 (22)
25 (1)
26 (55)
27 (85)
28 (60)
30 (1)
31 (34)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
30
31
Business
MilliporeSigma Signs Exclusive OEM Agreement with BioDuro, LLC
AISF was developed through a research collaboration with Pfizer Inc.
December 5, 2018
·
1 min read
Drug Development
Eyenovia Completes Patient Enrollment in MicroStat MIST-1 Study and Enrolls First Patient in MIST-2 Study
Topline results for the Phase III MicroStat Program for pharmacologic mydriasis expected H1 2019
December 5, 2018
·
3 min read
Policy
New Camera Requirements for Arkansas Non-Emergency Transportation Vehicles Carrying Medicaid Beneficiaries to Start in 2019, says Rear View Safety
Video system requirements will soon change for non-emergency transportation (NET) vehicles carrying Medicaid Beneficiaries in Arkansas. NET Contract (IFB 710-18-1025) states the following minimum requirements for video recording in NET vehicles, effective January 1st, 2019.
December 5, 2018
·
1 min read
Business
Theory explaining addiction wins Grawemeyer psychology award
University of Michigan researchers Kent Berridge and Terry Robinson have won the 2019 University of Louisville Grawemeyer Award for Psychology for explaining how our brains process “liking” versus “wanting” and how neural sensitization of the “wanting” system plays a key role in drug addiction.
December 5, 2018
·
2 min read
Business
H-PROOF Teams Up with iHeartMedia’s Z100 to Help Prevent Hangovers at the 2018 Z100 Jingle Ball Official After Party
H-PROOF—the first doctor-developed chewable tablet that helps prevent hangovers— is partnering with iHeartMedia’s Z100 as the official “Hangover Prevention Partner” for the 2018 Z100 Jingle Ball Official After Party.
December 5, 2018
·
1 min read
CPhI report forecasts India to have strongest global growth in 2019
CPhI & P-MEC India opens as report ranks India the world’s fastest improving pharma market and first for ‘growth potential’ for 2019
December 5, 2018
·
5 min read
Creative Diagnostics Launches ALK Pathway for Immunology Researchers
Creative Diagnostics has launched ALK Pathway to scientific community facing the growing challenges for immunology research.
December 5, 2018
·
2 min read
Drug Development
GENFIT: Launch of a U.S. Phase 2 investigator-initiated study with nitazoxanide in patients with NASH-induced fibrosis
- Phase 2 study targeting a patient population with NASH-induced Stage 2 or 3 fibrosis - Anti-fibrotic effect of nitazoxanide to be evaluated by several approaches including an innovative method to quantify hepatic fibrogenesis flux rates
December 5, 2018
·
6 min read
Drug Development
NEW DATA ON ASLAN003 PRESENTED AT ASH ANNUAL MEETING SHOWS FIRST SIGNS OF CLINICAL ACTIVITY OF A DHODH INHIBITOR IN ACUTE MYELOID LEUKAEMIA
Phase 2a study of ASLAN003 for the treatment of acute myeloid leukaemia (AML) at the 60th American Society of Hematology (ASH) Annual Meeting in San Diego, US.
December 5, 2018
·
7 min read
Pharm Country
InventHelp Inventor Develops Medical Sock For Heel Bed Sores (SFO-591)
An inventor from San Pablo, Calif., has developed the H-SOCK, a sock for the prevention of heel bed sores.
December 5, 2018
·
1 min read
Previous
15 of 19
Next